Search

Yanqin joined the laboratory In January 2022 after after perfecting analysis in two compartment models in the Laboratory of Zachery P. Bulman at the University of Illinois. In previous ventures, she was instrumental in the development of the MRX-1, also known as Contezalid, a new oxazalidinone...

Dr. Kirby is an NIH-funded Principal Investigator in the Experimental Pathology Division of Beth Israel Deaconess Medical Center; Professor of Pathology at Harvard Medical School, and Director of the Clinical Microbiology Laboratory at BIDMC; He is also a Fellow of the American Academy of...